Cancer Research and Treatment is the open-access journal of the Korean Cancer Association, publishing experimental and clinical cancer research. Read by oncologists in Korea and internationally, and it is a common home for Korean clinical trial reports.
Cancer Research and Treatment is a peer-reviewed open access publication of the Korean Cancer Association, the Korean Society of Medical Oncology and the Korean Association for Lung Cancer, published quarterly from Seoul. It accepts manuscripts on experimental and clinical cancer research, including carcinogenesis, tumour biology, molecular oncology, cancer genetics, tumour immunology, epidemiology, predictive markers and prevention, pathology, diagnosis, screening and therapies (chemotherapy, surgery, radiation therapy, immunotherapy, gene therapy, multimodality treatment and palliative care). NLM dates the present title to 2000, continuing the Korean-language Taehan Am Hakhoe chi, and records content in English and Korean. Indexed in MEDLINE, PubMed Central, KoreaMed, Scopus and SCI according to its aims page.
Joohyuk Sohn is a Yonsei breast oncologist and investigator on the DESTINY-Breast and TROPION trials.
Sang Joon Shin is a Yonsei medical oncologist active in colorectal cancer and melanoma immunotherapy trials.
Shares Radiotherapy, PubMed & Europe PMC.
Shares Radiotherapy, PubMed & Europe PMC.
Shares Chemotherapy, Immunotherapy.
Shares Radiotherapy, PubMed & Europe PMC.
Shares Chemotherapy, PubMed & Europe PMC.
Shares Radiotherapy, PubMed & Europe PMC.
Shares Radiotherapy, PubMed & Europe PMC.
Shares Chemotherapy, Radiotherapy.